Pliant Therapeutics GAAP EPS of -$0.38 in-line
Source: SeekingAlpha
2026-03-11 16:36:59 ET
More on Pliant Therapeutics
- Pliant Therapeutics, Inc. (PLRX) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
- Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration
- Seeking Alpha’s Quant Rating on Pliant Therapeutics
- Historical earnings data for Pliant Therapeutics
- Financial information for Pliant Therapeutics
Read the full article on Seeking Alpha
For further details see:
Pliant Therapeutics GAAP EPS of -$0.38 in-line
Pliant Therapeutics Inc.
NASDAQ: PLRX
PLRX Trading
-2.13% G/L:
$1.15 Last:
104,834 Volume:
$1.16 Open:
PLRX Latest News
May 21, 2026 05:29:30 pm
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 11, 2026 04:05:00 pm
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 06, 2026 08:30:00 am
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
PLRX Stock Data
$72,817,521
56,533,434
3.63%
28
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
